Template:Aifmdanatomy: Difference between revisions
Jump to navigation
Jump to search
Amwelladmin (talk | contribs) No edit summary |
Amwelladmin (talk | contribs) |
||
| Line 3: | Line 3: | ||
<small>'''Navigation - directive''' {{eudirective|2011|61|EU}}: {{aifmdprov|21}} | {{aifmdprov|21(8)}} | {{aifmdprov|36(1)}} </small><br> | <small>'''Navigation - directive''' {{eudirective|2011|61|EU}}: {{aifmdprov|21}} | {{aifmdprov|21(8)}} | {{aifmdprov|36(1)}} </small><br> | ||
<small>'''Navigation - implementing regulation''' {{euregulation|231|2013}}: {{aifmdprov|DR76}} ({{aifmdprov|objective reason}}) | {{aifmdprov|DR91 | <small>'''Navigation - implementing regulation''' {{euregulation|231|2013}}: {{aifmdprov|DR76}} ({{aifmdprov|objective reason}}) | {{aifmdprov|DR91}} ({{aifmdprov|reporting obligations for prime brokers}})</small> <br> | ||
<small>'''{{tag|AIFMD Anatomy}}'''</small> <br> | <small>'''{{tag|AIFMD Anatomy}}'''</small> <br> | ||
{{anatomybar}} | {{anatomybar}} | ||
{{c3|EU|AIFMD|Investment Funds}} | {{c3|EU|AIFMD|Investment Funds}} | ||
__NOTOC__ | __NOTOC__ | ||
Revision as of 15:05, 30 January 2015
====AIFMD==== This is an article about Alternative Investment Funds Management Directive (2011/61/EU (EUR Lex)) and the AIFMD Implementing Regulation 231/2013 (EUR Lex).
Navigation - directive 2011/61/EU (EUR Lex): 21 | 21(8) | 36(1)
Navigation - implementing regulation 231/2013 (EUR Lex): DR76 (objective reason) | DR91 (reporting obligations for prime brokers)
AIFMD Anatomy
Anatomy™: AIFMD | CASS | COBS | Conference calls | Confis | CRR | CSA | EMIR | Equity Derivatives | FOA PCA | FUND | GMRA | GMSLA | ISDA | OSLA | PB | Swapclear | UCITS